Silexion Therapeutics Corp (SLXN) Price Prediction & ForecastSLXNSilexion Therapeutics Corp

Alphio's SLXN stock price prediction model matches the current Silexion Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.14 (-1.07%). The 1-week path is $0.15 (+1.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Silexion Therapeutics Corp (SLXN) is not a good buy right now due to significant financial losses and poor stock performance. The current price is $0.14, which is a staggering 99.23% decline year-to-date. Additionally, the company reported a net loss of $3.55 million in Q2 2026, reflecting increased R&D expenses, and the RSI is at 34.941, indicating potential oversold conditions but not enough to warrant a buy. The main risk is the company's ongoing financial instability, with a forward P/E ratio of 0 and a price-to-book ratio of 49.72, suggesting overvaluation given its current financial state.

Silexion Therapeutics Corp (SLXN) last closed at $0.1441, gaining +0.21%. These facts feed the 1-day and 1-week SLXN price prediction above.